ATA111277A - Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten - Google Patents

Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten

Info

Publication number
ATA111277A
ATA111277A AT771112A AT111277A ATA111277A AT A111277 A ATA111277 A AT A111277A AT 771112 A AT771112 A AT 771112A AT 111277 A AT111277 A AT 111277A AT A111277 A ATA111277 A AT A111277A
Authority
AT
Austria
Prior art keywords
sulfonylbenzimidazole
derivatives
producing new
producing
new
Prior art date
Application number
AT771112A
Other languages
English (en)
Other versions
AT347937B (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/750,991 external-priority patent/US4118742A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA111277A publication Critical patent/ATA111277A/de
Application granted granted Critical
Publication of AT347937B publication Critical patent/AT347937B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
AT111277A 1976-12-15 1977-02-18 Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten AT347937B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/750,991 US4118742A (en) 1975-08-28 1976-12-15 Carbonyl-substituted 1-sulfonylbenzimidazoles

Publications (2)

Publication Number Publication Date
ATA111277A true ATA111277A (de) 1978-06-15
AT347937B AT347937B (de) 1979-01-25

Family

ID=25019992

Family Applications (1)

Application Number Title Priority Date Filing Date
AT111277A AT347937B (de) 1976-12-15 1977-02-18 Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten

Country Status (26)

Country Link
JP (1) JPS5377062A (de)
AR (1) AR225397A1 (de)
AT (1) AT347937B (de)
AU (1) AU509374B2 (de)
BE (1) BE851630A (de)
BG (1) BG27742A3 (de)
CA (1) CA1079737A (de)
CH (1) CH630368A5 (de)
CS (1) CS190339B2 (de)
DD (1) DD129445A6 (de)
DE (1) DE2706227A1 (de)
DK (1) DK145645C (de)
ES (1) ES456090A1 (de)
FR (1) FR2374311A2 (de)
GB (1) GB1568543A (de)
GR (1) GR66420B (de)
HU (1) HU175361B (de)
IE (1) IE44863B1 (de)
IL (1) IL51445A (de)
MX (1) MX4495E (de)
NL (1) NL187396C (de)
PL (1) PL106887B1 (de)
RO (1) RO71886A (de)
SE (2) SE433351B (de)
SU (1) SU680645A3 (de)
ZA (1) ZA77691B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420479A (en) * 1982-04-08 1983-12-13 Eli Lilly And Company Olefinic benzimidazoles, formulations, and antiviral methods
FR2593177B1 (fr) * 1986-01-20 1988-04-01 Novapharme Nouveaux benzimidazo
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
JP7226480B2 (ja) 2020-07-30 2023-02-21 大日本印刷株式会社 抗ウイルス性物品及び抗ウイルス性樹脂組成物
CN116209572A (zh) 2020-09-18 2023-06-02 大日本印刷株式会社 抗病毒性物品和抗病毒性树脂组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125078A (en) * 1974-07-01 1976-11-01 Lilly Co Eli Production of substituted 11sulphonylbenzimidazole

Also Published As

Publication number Publication date
SU680645A3 (ru) 1979-08-15
DK73277A (da) 1978-06-16
GB1568543A (en) 1980-05-29
AU509374B2 (en) 1980-05-08
DK145645B (da) 1983-01-10
ES456090A1 (es) 1978-05-16
PL106887B1 (pl) 1980-01-31
FR2374311B2 (de) 1979-03-23
AR225397A1 (es) 1982-03-31
CH630368A5 (en) 1982-06-15
HU175361B (hu) 1980-07-28
JPS6229429B2 (de) 1987-06-25
AU2244077A (en) 1978-08-24
PL196131A1 (pl) 1978-06-19
DE2706227A1 (de) 1978-06-22
SE433351B (sv) 1984-05-21
BE851630A (fr) 1977-08-18
AT347937B (de) 1979-01-25
MX4495E (es) 1982-05-21
JPS5377062A (en) 1978-07-08
SE7701845L (sv) 1978-06-16
IL51445A (en) 1981-02-27
FR2374311A2 (fr) 1978-07-13
NL187396B (nl) 1991-04-16
NL7701715A (nl) 1978-06-19
DD129445A6 (de) 1978-01-18
IL51445A0 (en) 1977-04-29
RO71886A (ro) 1982-09-09
NL187396C (nl) 1991-09-16
CS190339B2 (en) 1979-05-31
SE8008090L (sv) 1980-11-18
DK145645C (da) 1983-07-11
IE44863L (en) 1978-06-15
DE2706227C2 (de) 1989-09-07
CA1079737A (en) 1980-06-17
BG27742A3 (en) 1979-12-12
SE433352B (sv) 1984-05-21
GR66420B (de) 1981-03-20
IE44863B1 (en) 1982-04-21
ZA77691B (en) 1978-09-27

Similar Documents

Publication Publication Date Title
AT356827B (de) Verfahren zur herstellung von neuen spirol- actonen
AT358727B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT356136B (de) Verfahren zur herstellung von neuen spiro- hydantoinen
AT359187B (de) Verfahren zur herstellung von neuen 7-beta-(2- -oxyimino-2-arylacetamido)-cephalosporinen
AT363478B (de) Verfahren zur herstellung von neuen oxepanderivaten
AT365611B (de) Verfahren zur herstellung von neuen 17alpha-(3-r2-oxypropyl)-17beta-r1-oxy-4-gonen-onen
AT352120B (de) Verfahren zur herstellung von neuen benzoxocin- derivaten
AT360185B (de) Verfahren zur herstellung von neuen dehydro- digopeptiden
AT356655B (de) Verfahren zur herstellung von neuen benzodia- zepinderivaten
AT353987B (de) Verfahren zur herstellung von neuen spirooxazolidindionen
AT347937B (de) Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten
AT362786B (de) Verfahren zur herstellung von neuen 1-acyl-2-imidazolinen
AT358726B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT361928B (de) Verfahren zur herstellung von neuen chinolonderivaten
AT351191B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT375931B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten
AT364364B (de) Verfahren zur herstellung von neuen thiepinen
AT362349B (de) Verfahren zur herstellung von neuen 3-amino-2- -hydroxypropoxyaryl-derivaten
AT343623B (de) Verfahren zur herstellung von neuen n-alkyl -4-nitro-2- trifluormethyldiphenylaminen
AT360646B (de) Verfahren zur herstellung von neuen cephalos- porinen
ATA656076A (de) Verfahren zur herstellung von neuen d-homo- steroiden
ATA175879A (de) Verfahren zur herstellung von neuen antitumorglycosiden
AT347962B (de) Verfahren zur herstellung von neuen thienothiazinderivaten
AT361466B (de) Verfahren zur herstellung von neuen tiophen- derivaten
AT355210B (de) Verfahren zur herstellung von neuen 1-oxa- dethiacephalosporinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee